NCT06979973View on ClinicalTrials.gov

A Drug-drug Interaction Study to Investigate the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Rosuvastatin in Healthy Adult Male Participants

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 14, 2025

Primary Completion Date

August 16, 2025

Study Completion Date

August 16, 2025

Conditions
Healthy
Interventions
DRUG

Midazolam

midazolam syrup

DRUG

Rosuvastatin

Rosuvastatin

DRUG

CKD-508 Tablet

CKD-508

Trial Locations (1)

91206

Research Site, Glendale

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT06979973 - A Drug-drug Interaction Study to Investigate the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Rosuvastatin in Healthy Adult Male Participants | Biotech Hunter | Biotech Hunter